Loading stock data…

© 2026 Whystock · Bureau7 LLC. Intelligent Financial Insights.

Not financial advice. Data may be delayed. Use at your own risk.

Stock Glossary Popular Stocks Stock ScreenerPrivacy Terms

Why JANX? Janux Therapeutics, Inc. Analysis, Price & AI Insights | Whystock

JANX

$14.34-0.03 (-0.21%)

Market ClosedLast close May 1

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms technology to treat patients with cancer.

Overview Intraday ResearchPRO BacktestPRO Ask AIPRO TranscriptsPRO StatementsPRO

Intraday

Custom Range:

to

No data available for this range. Intraday data may be limited by the exchange.